Previous 10 | Next 10 |
Biotech investors live and die by the binary news events generated by the drugmakers they invest in. Heron Therapeutics (NASDAQ: HRTX) , for instance, is awaiting a decision from the Food and Drug Administration about its candidate HTX-011 for use in post-operative pain. Likewise, ...
Alkermes to Take Part in the BofA Securities 2021 Virtual Healthcare Conference PR Newswire DUBLIN , May 5, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the BofA Securities...
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month - New Outcomes Research in Patients With Schizophrenia or Bipolar I Disorder to be Presented - PR Newswire DUBLIN , May 3, 2021 /PR...
Biopharma company Alkermes (ALKS), which was targeted by activist investor Elliott Management last year, has reached an agreement with Sarissa Capital, giving the activist fund the right to designate a director for the company's board.The agreement follows "constructive" dialogue between...
Alkermes Announces Agreement with Sarissa Capital Grants Sarissa Right to Designate Director to Alkermes' Board PR Newswire DUBLIN , April 30, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it has reached an agreement with Sarissa C...
Image source: The Motley Fool. Alkermes PLC (NASDAQ: ALKS) Q1 2021 Earnings Call Apr 29, 2021 , 8:00 p.m. ET Operator Continue reading For further details see: Alkermes PLC (ALKS) Q1 2021 Earnings Call Transcript
Alkermes Plc (ALKS) Q1 2021 Earnings Conference Call April 28, 2021, 08:00 ET Company Participants Sandra Coombs - Co-Head, IR Richard Pops - Chairman & CEO Iain Brown - Senior VP & CFO Todd Nichols - SVP & Chief Commercial Officer Conference Call Participants Brandon Folkes - Can...
The following slide deck was published by Alkermes plc in conjunction with their 2021 Q1 earnings call. For further details see: Alkermes plc 2021 Q1 - Results - Earnings Call Presentation
Alkermes (ALKS) reported first-quarter results that beat Wall Street estimates, as the company kept a tight lid on costs and was helped by the strength in its proprietary products segment.Shares up more than 2% premarket.Total operating expenses for the quarter were $267.9M, co...
Alkermes (ALKS): Q1 Non-GAAP EPS of $0.11 beats by $0.12; GAAP EPS of $0.14 beats by $0.49.Revenue of $251.4M (+2.1% Y/Y) beats by $16.17M.At Mar. 31, 2021, Alkermes recorded cash, cash equivalents and total investments of $627.4M, compared to $659.8M at Dec. 31, 2020. Total debt outstanding ...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...